In particular, the presence of tumor derived inhibitory molecules such as interleukin (IL-6, 10), transforming growth factor beta (TGFβ) and VEGF produced by the tumor negatively impact the growth, maturation and differentiation of DCs (116, 117). This evidence concerns the gene IL6 and neoplasm.